Metabolic Health with Dr. Lindsay Ogle, MD

According to the video, Dr. Lindsay Ogle, an obesity medicine physician who runs a telehealth practice in Missouri, reviews a new multi-dose Zepbound pen available through Lilly Direct. She says Lilly Direct previously offered Zepbound only as single-use vials.

1. 0:00 Introduction to Zepbound
2. 2:16 Understanding the new pen
3. 4:41 Operating instructions
4. 8:47 Split dosing benefits
5. 12:30 Cost-saving strategies
6. 15:07 Conclusion and resources

• Doses mentioned: 2.5 mg, 5 mg, 10 mg and 15 mg
• Prices mentioned: $75 a month
• Who is speaking: Clinician, MD

Dr. Lindsey Ogle, who describes herself as a board-certified obesity medicine physician, walks through how to use the Zepbound multi-dose QuickPen using a demo pen with no medication in it.

• Doses mentioned: 2.5 mg and 15 mg
• Who is speaking: Clinician, MD

Dr. Lindsay Ogle, an obesity medicine physician, says fatigue is a common complaint among her patients on GLP-1 medications. She stresses that the first step is working out why someone is tired, because the right fix depends on the cause.

1. 0:00 Introduction to GLP-1 fatigue
2. 1:05 Addressing underfueling
3. 7:13 Micronutrient deficiencies
4. 18:08 Managing sleep quality
5. 24:32 Physiologic fatigue and wrapup

• Side effects mentioned: fatigue and low appetite
• Who is speaking: Clinician, MD

In this video, Dr. Lindsay Ogle explains the questions she works through with patients before deciding whether to raise a GLP-1 dose. She says she sees patients monthly at first, then every 2 to 3 months once they reach maintenance.

1. 0:00 Intro
2. 0:55 When to increase the dose
3. 2:37 Side effects
4. 3:48 Positive benefits
5. 8:36 Mindset
6. 10:29 Cost

• Side effects mentioned: nausea and low appetite
• Who is speaking: Clinician, MD

Dr. Lindsay Ogle, who introduces herself as a board-certified obesity medicine physician, explains what she says people can consider once they reach their health goal on a GLP-1 medication.

1. 0:00 Managing GLP-1 medications
2. 1:41 Obesity and treatment duration
3. 4:22 New indications and benefits
4. 6:19 The process of titrating off
5. 8:26 Maintenance strategies
6. 10:50 Lifestyle and long-term health

• Doses mentioned: 0.25 mg and 2.5 mg
• Who is speaking: Clinician, MD

In this video, Dr. Lindsay Ogle, an obesity medicine specialist, reviews orforglipron, sold as Foundayo, which she describes as the newest FDA approved obesity medication. She explains that it is an oral, non-peptide GLP-1 medication.

1. 0:00 Introduction
2. 3:39 Side effects
3. 6:00 Dose change
4. 16:33 Food noise and cravings
5. 18:46 Cost and insurance

• Side effects mentioned: nausea and constipation
• Prices mentioned: $299 a month
• Who is speaking: Clinician, MD

In this video, Dr. Lindsay Ogle, who describes herself as a board-certified family medicine and obesity medicine physician, lays out seven strategies she uses with patients to prevent and manage nausea on a GLP-1 medication.

1. 0:00 <Untitled Chapter 1>
2. 1:30 Tip #1
3. 5:31 Tip #2
4. 6:23 Tip #3
5. 7:25 Tip #4
6. 8:57 Tip #5
7. 10:28 Tip #6
8. 11:15 Tip #7

• Doses mentioned: 2.5 mg and 25 mg
• Side effects mentioned: nausea, constipation and dehydration
• Who is speaking: Clinician, MD

Dr. Lindsay Ogle, who describes herself as a board-certified family medicine and obesity medicine physician, introduces the Medicare GLP-1 Bridge Program.

1. 0:00 Medicare bridge program
2. 1:47 Qualifying criteria
3. 6:39 Additional eligibility paths
4. 9:26 GLP-1 use in seniors
5. 10:56 Safety and support team
6. 13:27 Health optimization tips
7. 16:48 Monitoring and osteoporosis

• Side effects mentioned: fatigue, dizziness and dehydration
• Prices mentioned: $50 a month, $450 a month and $20 a month
• Who is speaking: Clinician, MD

Dr. Lindsay Ogle, who describes herself as a board-certified family medicine and obesity medicine physician, reviews the newly FDA-approved oral version of Wegovy.

1. 0:00 Introduction to oral Wegovy
2. 1:39 Comparison with Rybelsus
3. 4:49 GLP-1 myths and technology
4. 7:22 Pricing and clinical efficacy
5. 9:44 Correct usage and dosing
6. 11:03 Side effects and management
7. 14:41 Patient suitability
8. 17:41 Contraindications and summary

• Doses mentioned: 1.5 mg, 4 mg and 25 mg
• Side effects mentioned: nausea and constipation
• Prices mentioned: $149 a month, $199 a month and $50 a month
• Who is speaking: Clinician, MD

In this episode of her podcast, the host, a board-certified obesity medicine physician, gives an overview of the new 7.2 mg dose of Wegovy. She says it was FDA-approved in March 2026 and, as of her April 1, 2026 recording, was expected to become available later that month.

1. 0:00 Introduction to high-dose Wegovy
2. 2:22 Dosing and clinical study overview
3. 4:27 Study results and weight loss efficacy
4. 7:15 The role of medical treatment
5. 8:23 Diabetes and early intervention
6. 10:46 Side effects and safety profile
7. 12:48 Candidate selection and conclusion

• Doses mentioned: 0.25 mg, 1 mg, 2.4 mg and 7.2 mg
• Side effects mentioned: nausea, constipation and heartburn or reflux
• Who is speaking: Clinician, MD